2025 Regular Session • Texas Legislature
HB632
Legislative Summary
Relating to the regulation of the practice of pharmacy.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
11/12/2024
Filed
House of Representatives
3/4/2025
Read first time
House of Representatives
3/4/2025
Referred to s/c on Dis Prev & Women's & Children's Health by Speaker
House of Representatives
4/17/2025
Scheduled for public hearing in s/c on . . .
House of Representatives
4/17/2025
Considered by s/c in public hearing
House of Representatives
4/17/2025
Testimony taken/registration(s) recorded in subcommittee
House of Representatives
4/17/2025
Left pending in subcommittee
House of Representatives
4/24/2025
Recalled from subcommittee
House of Representatives
4/24/2025
Considered in formal meeting
House of Representatives
4/24/2025
Reported favorably w/o amendment(s)
House of Representatives
Status Information
Current Status
Introduced(11/12/2024)
Chamber
House of Representatives
Committee
Dis Prev & Women's & Children's Health Subcommittee(House of Representatives)
Sponsors
Democrat: 1
Primary Sponsor
John Bucy
Democrat